Employers face a demanding health and well-being agenda in 2026 as affordability pressures, ecosystem fragmentation and regulatory movement converge. Business Group on Health’s 2026 analysis projects a 9% cost trend, easing to 7.6% with plan design changes, alongside double-digit increases in some regions. Attention is turning to pharmacy spend, vendor accountability and the rapid integration of artificial intelligence across benefits and care. Prevention, screening adherence and support for caregiving are rising in importance as organisations seek measurable outcomes. The focus is shifting from broad programme expansion to disciplined execution, clearer accountability and data that demonstrates value for employees and families.
Costs and Pharmacy Pressures Reshape Plan Design
Affordability remains the dominant concern after successive years in which actual costs exceeded forecasts. The projected 9% cost trend, moderated to 7.6% through plan adjustments, reflects sustained pressures from chronic conditions, rising medical and pharmacy prices and an increasingly complex delivery landscape. Employers are responding with frank internal budgeting, tighter programme evaluation and a willingness to consolidate or replace underperforming partners. Decisions are concentrating on high-cost drivers and the arrangements with providers and vendors that influence access, quality and total spend.
Must Read: Patient Trends in 2025: Transforming Care and Empowerment
Pharmacy spend warrants particular scrutiny. Cell and gene therapies and weight-loss medicines promise clinical benefits but carry substantial near- and long-term cost implications. Intermediaries in the medicines supply chain face pressure to improve transparency around pricing, compensation and utilisation policies. Manufacturers are under similar scrutiny as government initiatives progress through various coverage channels and direct-to-consumer offerings. Visible cash-pay prices in high-demand classes such as GLP-1s challenge the relevance of traditional medicines coverage for some segments. Employers are assessing how cash-pay and direct channels interact with utilisation management and plan design. For multinationals, potential moves toward an MFN-style pricing approach in one jurisdiction could raise prices elsewhere, necessitating closer monitoring of local costs and public coverage.
Back to Basics, Vendor Accountability and Alternative Models
Fundamentals are back in focus. Chronic diseases continue to drive spend, with expectations of increased condition management needs aligned to ageing and worsening population health. Strategies prioritise prevention, primary care engagement and adherence to recommended screenings, supported by communications that account for cultural and access differences across operating regions. Some organisations are exploring incentives and plan features that reward continued primary care use and age-appropriate screening to improve uptake and outcomes.
Programme rationalisation accompanies this shift. Leadership scrutiny is intensifying on well-being investments for diabetes, cardiac conditions and obesity, with decisions grounded in organisational data on clinical and economic performance. Employers aim to reduce duplication, enforce coordination and hold partners to clearer performance standards. Vendors are expected to demonstrate measurable results, share usable data, collaborate across programmes and accept enhanced accountability. Contract transparency and verification rights are moving to the centre of negotiations as organisations seek assurance that promised value is delivered.
Alternative plan models are expanding. Options include co-payment-based structures, virtual-first approaches, primary care-centred designs and network-less plans, offered by both established carriers and newer entrants. Technology and AI are enabling novel configurations, yet careful comparison remains essential. Consultants and advisers are expected to evaluate these offerings alongside traditional designs and recommend options aligned with objectives, workforce needs and risk tolerance.
AI Momentum and Regulatory Shifts Redefine Employer Roles
AI is advancing across benefits administration and care delivery. Administratively, it offers potential to reduce burden, improve communication and personalise navigation, enabling benefits teams to redirect effort to strategy. Employees may begin to expect AI-supported guidance across programmes and care choices. In clinical settings, AI can accelerate evidence adoption and expand access, though it can also be deployed to optimise provider revenue, with possible cost implications. Employers are assessing where AI appears in intake and basic care, and how vendor applications support health and well-being goals. Some organisations may pilot internal initiatives or learn from early adopters to reshape communications, benefits and programme design.
Regulatory movement remains a defining variable with implications for compliance, fiduciary duties and enforcement. Measures targeting medicines supply chain practices sit alongside broader transparency expectations. Changes to preventive care guidance, screening recommendations and chronic condition management may vary across jurisdictions, requiring clear communication about timely access to preventive and ongoing care. Shifts in public coverage and subsidy mechanisms can influence eligibility, premiums and reliance on employer-sponsored coverage, including through a spouse or partner. Organisations are monitoring these developments to prepare plan adjustments and targeted support as needed.
Additional trends are sharpening. Employees increasingly view employers as trusted health information sources, requiring evidence-based responses to conflicting messages on risk, screening, vaccination and treatment. Caregiving is emerging as a material health risk factor, associated with elevated physical, mental and financial risks and prompting reassessment of benefits, policies and local support infrastructure. Longevity and multigeneration workforces are driving demand for hyper-personalised access, digital navigation and inclusive design. Conflicts, climate-related disasters and sudden emergencies continue to affect physical and mental health and financial well-being, underscoring the need for rapid support in collaboration with partners.
The 2026 agenda calls for disciplined action on costs, pharmacy strategy and vendor performance, underpinned by prevention, primary care engagement and credible measurement. Employers weighing alternative plan models and expanding AI capabilities are setting firmer expectations for transparency, coordination and demonstrable value. With regulatory shifts reshaping obligations and access, and with evolving workforce needs, success depends on clear priorities, robust data and pragmatic execution that protect affordability and improve health outcomes.
Source: Business Group on Health
Image Credit: iStock
